AKR1C3 is a biomarker and druggable target for oropharyngeal tumors
2020 · Cellular Oncology · 17 citations
https://doi.org/10.1007/s13402-020-00571-z
A
Andrea Carenzo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
237
Citations
9
h-index
8
i10-index
Andrea Carenzo is an academic researcher from Fondazione IRCCS Istituto Nazionale dei Tumori. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Neurofibromatosis and Schwannoma Cases & Cancer-related molecular mechanisms research. The author has an h-index of 9, co-authored 29 publications.
ORCID: 0000-0001-6804-9984Papers by this author
worksBiological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials
2022 · Oral Oncology · 5 citations
https://doi.org/10.1016/j.oraloncology.2022.105756
Gene expression-based dissection of inter-histotypes, intra-histotype and intra-tumor heterogeneity in pediatric tumors
2022 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-022-20536-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat